+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy

Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy

Neuropharmacology 45(4): 493-503

The possible synergism between caffeine and muscarinic antagonists to inhibit haloperidol-induced catalepsy was investigated with the bar test in rats. Pretreatment with low doses of caffeine (1-3 mg/kg), a non-selective adenosine antagonist, dose dependently reduced the intensity and increased the onset latency of catalepsy induced by haloperidol (0.5-2 mg/kg). Similar effects were produced by the muscarinic antagonists atropine (4.1 mg/kg), and trihexyphenidyl (THP, 0.01-3 mg/kg). THP inhibited catalepsy intensity with an ED50 of 0.38 mg/kg, and increased its onset latency with an ED50 of 0.52 mg/kg. The anticataleptic effect of anticholinergics was potentiated when a low dose of caffeine (1 mg/kg) was applied simultaneously. In the presence of caffeine, THP inhibited catalepsy intensity with an ED50 of 0.19 mg/kg, and prolonged the latency with an ED50 of 0.30 mg/kg. The synergism was more evident when THP was administered at subthreshold doses that were unable to modify haloperidol-induced catalepsy when applied alone, but produced a clear inhibition of catalepsy when injected with caffeine. To assess whether repeated administration of caffeine could induce tolerance to the synergism with THP, a group of rats was pretreated with three daily doses of caffeine (1 mg/kg) for seven days, and the catalepsy test was performed on the eighth day. In these animals, caffeine was still able to enhance the anticataleptic actions of THP, suggesting that repeated administration of 1 mg/kg caffeine does not induce tolerance to the synergism with anticholinergics. These results indicate that low doses of caffeine enhance the anticataleptic actions of muscarinic antagonists, and leave open the possibility of using caffeine as adjunctive therapy to reduce the doses and the adverse effects of anticholinergics in Parkinson's disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 010267262

Download citation: RISBibTeXText

PMID: 12907310

DOI: 10.1016/s0028-3908(03)00202-8

Related references

Low doses of caffeine act synergically with anticholinergics to inhibit haloperidol induced catalepsy. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 165 3, 2002

Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats. Eksperimental'naia i Klinicheskaia Farmakologiia 64(4): 10-12, 2001

The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes. Neuropharmacology 81: 176-187, 2014

Effect of caffeine on haloperidol induced catalepsy in the rat. Journal of Catholic Medical College 45(1): 327-335, 1992

Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists. Polish Journal of Pharmacology 49(5): 323-327, 1998

Haloperidol-induced catalepsy is influenced by calcium channel antagonists. Acta Poloniae Pharmaceutica 57(3): 233-237, 2001

Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice. Japanese Journal of Pharmacology 42(1): 79-85, 1986

Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. Neuroscience Letters 463(3): 210-214, 2009

Dopamine D-3 receptor blockade does not inhibit motor behavior and reduces haloperidol-induced catalepsy. Society for Neuroscience Abstracts 21(1-3): 618, 1995

5Ht2-receptor antagonists can attenuate submaximal haloperidol-induced catalepsy in rats. Schizophrenia Research 15(1-2): 153-154, 1995

Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34(8): 1465-1471, 2011

Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy. Naunyn-Schmiedeberg's Archives of Pharmacology 311(2): 179-184, 1980

The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats. European Journal of Pharmacology 572(2-3): 171-174, 2007

5-HT1A receptor activation and anti-cataleptic effects: High-efficacy agonists maximally inhibit haloperidol-induced catalepsy. European Journal of Pharmacology 453(2-3): 217-221, 25 October, 2002

Differentiation between catalepsy induced by levo tetra hydro palmatine and catalepsy induced by haloperidol and morphine. Acta Pharmacologica Sinica 2(3): 152-155, 1981